Blocking the TLR4/NF-κB Cascade Reverses the Promotion Effect of Overexpression of REB2 on Liver Injury and Inflammation in NAFLD Rats. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.